1. P470: NGS-BASED MINIMAL RESIDUAL DISEASE DETECTION IN PERIPHERAL BLOOD SHOWS GOOD PROGNOSTIC VALUE FOR OS AND EFS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECRUITED IN THE UNIFY TRIAL. (23rd June 2022) Authors: Thiede, C.; Schuster, C.; Krippendorf, C.; Koenen, G.; Medts, T.; Marques Ramos, P.; Gou, L.; Montesinos, P.; Fiedler, W.; Müller, R.; Krauter, J.; Sica, S.; Westermann, J.; Levis, M.; Stone, R.; Sierra, J.; Döhner, H. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗